摘要
Hepatitis B virus(HBV)is a widely prevalent liver infection that can cause acute or chronic hepatitis.Although current treatment modalities are highly effective in the suppression of viral levels,they cannot eliminate the virus or achieve definitive cure.This is a consequence of the complex nature of HBV-host interactions.Major challenges to achieving sustained viral suppression include the presence of a high viral burden from the HBV DNA and hepatitis B surface antigen(HBsAg),the presence of reservoirs for HBV replication and antigen production,and the HBV-impaired innate and adaptive immune response of the host.Those therapeutic methods include cell entry inhibitors,HBsAg inhibitors,gene editing approaches,immune-targeting therapies and direct inhibitors of covalently closed circular DNA(cccDNA).Novel approaches that target these key mechanisms are now being studied in preclinical and clinical phases.In this review article,we provide a comprehensive review on mechanisms by which HBV escapes elimination from current treatments,and highlight new agents to achieve a definitive HBV cure.
